Health care stocks were declining premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.1% lower and the iShares Biotechnology ETF (IBB) down 0.8%.
Merck (MRK) has dropped its bid to acquire Revolution Medicines (RVMD) over a disagreement on price, The Wall Street Journal reported, citing unnamed people familiar with the matter. Shares of Revolution Medicines were down 21% pre-bell.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments